These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28148942)

  • 1. John Jenkins.
    Nat Rev Drug Discov; 2017 Feb; 16(2):80. PubMed ID: 28148942
    [No Abstract]   [Full Text] [Related]  

  • 2. False hope with the Right to Try Act.
    The Lancet
    Lancet; 2018 Jun; 391(10137):2296. PubMed ID: 29900858
    [No Abstract]   [Full Text] [Related]  

  • 3. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 4. The Emergency Drug Release Program: regulatory aspects of new drug access in Canada.
    Gilron I
    CMAJ; 1993 Apr; 148(7):1151-3. PubMed ID: 8457955
    [No Abstract]   [Full Text] [Related]  

  • 5. The challenge of regulating development and approval of drugs with pleiotropic action in cardiovascular disease.
    Temple R
    Am J Cardiol; 1998 Apr; 81(8A):5F-9F. PubMed ID: 9604896
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunobiologics and drugs available from the Centers for Disease Control.
    Becher JA; Parvin RM; Van Assendelft OW
    J Pharm Technol; 1989; 5(4):181-6. PubMed ID: 10314382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulations and procedures for new drug evaluation and approval in China.
    Yin H
    Hum Gene Ther; 2006 Oct; 17(10):970-4. PubMed ID: 16958562
    [No Abstract]   [Full Text] [Related]  

  • 8. [Status of drugs].
    Gindre I; Woronoff-Lemsi MC
    Soins; 1998 Nov; (630):57-8. PubMed ID: 10095734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Following together the road to accessing innovative therapies: a few landmarks].
    Cottet C
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():57-59. PubMed ID: 30943167
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs on trial.
    Rawlins M; Jeffreys D
    Practitioner; 1994 Jul; 238(1540):508-12. PubMed ID: 7937503
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanded access to investigational drugs.
    Sarpatwari A; Darrow JJ; Kesselheim AS
    N Engl J Med; 2015 Apr; 372(15):1473-4. PubMed ID: 25853762
    [No Abstract]   [Full Text] [Related]  

  • 12. Expanded access to investigational drugs.
    Lurie P; Chan-Tack KM; Woodcock J
    N Engl J Med; 2015 Apr; 372(15):1473. PubMed ID: 25853763
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to unapproved drugs.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):2-4. PubMed ID: 20345193
    [No Abstract]   [Full Text] [Related]  

  • 14. A new era in drug regulation?
    Dresser R
    Hastings Cent Rep; 2005; 35(3):10-1. PubMed ID: 16092391
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulating new psychoactive drugs: innovation leading to compromise.
    Schep LJ; Gee P; Tingle M; Galea S; Newcombe D
    BMJ; 2014 Aug; 349():g5085. PubMed ID: 25122194
    [No Abstract]   [Full Text] [Related]  

  • 16. US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access Programs.
    Kim T; Lurie P; Pazdur R
    J Clin Oncol; 2015 Nov; 33(33):3979-80. PubMed ID: 26282656
    [No Abstract]   [Full Text] [Related]  

  • 17. New regulations on experimental drugs in Italy.
    Dell'Aera M; Pragnell MV; Lattarulo M
    Am J Health Syst Pharm; 1996 Oct; 53(20):2521. PubMed ID: 8899128
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulatory watch: Why do oncology drugs fail to gain US regulatory approval?
    Khozin S; Liu K; Jarow JP; Pazdur R
    Nat Rev Drug Discov; 2015 Jul; 14(7):450-1. PubMed ID: 26000722
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical, legal, and ethical issues in expanded access to investigational drugs.
    Darrow JJ; Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2015 Jan; 372(3):279-86. PubMed ID: 25587952
    [No Abstract]   [Full Text] [Related]  

  • 20. TransMolecular receives FDA approval for 131-I-TM-601 IND application.
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):139. PubMed ID: 12113233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.